$4.35
-0.45-9.38%
At close: -
$4.35
00.00%
After Hours: Nov 15, 4:01 PM EDT
Comments
Loading...
Kyverna Therapeutics (NASDAQ:KYTX) Stock, Earnings Estimates, EPS, And Revenue
Kyverna Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 12
EPS Estimate
$-0.920
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Kyverna Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Kyverna Therapeutics (KYTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.80 | $-0.80 | 0.00 % |
| Jun 2024 | 2024-08-12 | $-0.67 | $-0.64 | -4.69 % |
| Mar 2024 | 2024-05-14 | $-1.12 | $-0.84 | -33.3 % |
Kyverna Therapeutics (KYTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Kyverna Therapeutics (NASDAQ:KYTX) reporting earnings?
Kyverna Therapeutics (KYTX) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Kyverna Therapeutics (NASDAQ:KYTX)?
The Actual EPS was $-0.80, which hit the estimate of $-0.80.
What were Kyverna Therapeutics’s (NASDAQ:KYTX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.